Humira biosimilar to see $832 million in sales by 2029: GlobalData
Humira’s 52-week study evaluated adalimumab’s efficacy and safety for moderate-to-severe psoriasis, exploring continuous against…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Biocon acquires manufacturing facility of Eywa Pharma
The facility is acquired for a total consideration of $7.7 million
Cybersecurity dominates pharma industry discussions during Q2 2023: GlobalData
GlobalData’s “Company Filings Analytics Trends & Signals Q2 2023” report reveals that Europe emerged as a key geography in…
Zydus gets US FDA approval for Isotretinoin Capsules USP, 10 mg, 20 mg 30 mg and 40 mg
Isotretinoin Capsules is used to treat severe cystic acne (also known as nodular acne) that has not responded to other treatment
BioNTech to lead $2 bn mRNA-based oncology therapy market despite challenges: GlobalData
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials, predominantly targeting solid tumors…
Ajanta gets US FDA approval for Topiramate ER Capsules
As per the settlement with the innovator, Ajanta can launch Topiramate on February 1, 2026 or earlier under certain circumstances
Strides gets USFDA approval for Mycophenolate Mofetil for Oral Suspension
The products will be manufactured at the company’s facility in Bengaluru
J&J’s Akeega FDA approval to heat up PARP battle with dual-action treatment for prostate…
Akeega’s current predicted sales will experience only a slight increase as a result of its narrow label and fierce competition…
BDR Pharma launches Dalbonova Injection for acute bacterial skin infections
Dalbonova offers single-dose therapy for acute bacterial skin and skin structure infections (ABSSSI) in patients of all ages,…
Venus Remedies gets Saudi marketing approval for Enoxaparin in PFS
The company expects this marketing approval to enable it to rapidly expand its operations not only in Saudi Arabia but other GCC…
Shiva Pharmachem files DRHP for Rs 900 cr IPO
The IPO with a face value of Rs 2 each is entirely an offer for sale (OFS) of up to Rs 900 crore by Promoter and Promoter Group…
Marksans receives USFDA approval for Guaifenesin ER Tablets (OTC)
Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways…
Top 20 global biopharma companies report 2.3 per cent market cap growth in Q2 2023: GlobalData
Market cap surged from $3.49 trillion during the first quarter (Q1) of 2023 to $3.56 trillion in Q2 2023
US FDA approves ABRYSVO, Pfizer’s maternal RSV vaccine for infants
First and only US approval of a maternal vaccine to help protect infants at birth through six months of life from lower…
Avantor inaugurates expanded Singapore hub
Facility to serve AMEA’s biopharma industry
Hikal gets Brazilian GMP certification and US FDA EIR for Bangalore and Panoli facilities
Hikal has five manufacturing facilities in India at Maharashtra (Taloja and Mahad), Gujarat (Panoli) and Bengaluru (Jigani) and a…
Parexel, Partex announce alliance to leverage AI, Big Data to accelerate drug discovery and…
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better…
Venus Remedies launches its flagship R&D drug Elores in Oman
The antibacterial market in Oman is worth $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
Glenmark gets ANDA approval for Tacrolimus Ointment, 0.03%
Glenmark’s Tacrolimus Ointment, 0.03%, will be distributed in the US by Glenmark Pharmaceuticals, US
Lupin gets US FDA nod for Bromfenac Ophthalmic Solution, 0.09%; Metoprolol Succinate ER Tablets USP
Both products will be manufactured at Lupin’s Pithampur facility in India